Biofortuna secures more venture capital cash to ramp up US efforts
Molecular diagnostics business Biofortuna has closed another round of venture capital funding so that it can target the US market.
News
Molecular diagnostics business Biofortuna has closed another round of venture capital funding so that it can target the US market.
News
Partner content
Accounting and Finance Software
Accounting and Finance Software